OmniComm buys more EDC assets
OmniComm has acquired Logos Technologies’ electronic data capture (EDC) assets, the second deal of this type it has made in the past 6 weeks, further strengthening its presence in the market.
OmniComm has acquired Logos Technologies’ electronic data capture (EDC) assets, the second deal of this type it has made in the past 6 weeks, further strengthening its presence in the market.
Lonza has launched a fixed-price manufacturing service for up to 1000mg of microbial derived pharmaceuticals.
West Pharmaceutical Services’ operating income fell by 33 per cent in Q2 but the company reported that demand for some of its drug delivery technology is strong.
Ampac Fine Chemicals revenues fell by 20 per cent in Q3 as a result of a customer scaling back their order for central nervous system (CNS) products.
The FDA and EMEA are launching an 18 month pilot programme focused on good clinical practice (GCP), which is intended to increase collaboration and reduce the burden on the agencies.